Management of Kommerell’s diverticulum associated with aberrant subclavian artery reconstruction remains controversial, partly because it is such a rare anomaly. Airway compromise is uncommon and typically presents early in life. Difficulties with swallowing are frequent and are often underestimated by both patients and clinicians. Most patients present as adults, presumably because of ongoing diverticular growth. The diverticulum represents the remnant of the fourth primitive dorsal arch and is typically seen as a conical origin of the aberrant vessel. Even when its absolute size is only mildly increased, the vessel is rather thin and friable, possibly reflecting the failed tissue involution programming. Because of such intrinsic tissue abnormality, Backer and colleagues [1Backer C.L. Russell H.M. Wurlitzer K.C. et al.Primary resection of Kommerell diverticulum and left subclavian artery transfer.Ann Thorac Surg. 2012; 94: 1612-1618Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar] had proposed a ratio of 1.5 between the diameter at the mouth of the diverticulum and at the distal subclavian as the trigger to consider intervention. In this issue of The Annals of Thoracic Surgery, Ikeno and colleagues [2Ikeno Y. Koda Y. Yokawa K. et al.Graft replacement of Kommerell diverticulum and in situ aberrant subclavian artery reconstruction.Ann Thorac Surg. 2019; 107: 770-779Abstract Full Text Full Text PDF PubMed Scopus (13) Google Scholar] report excellent results of surgical treatment of aberrant subclavian artery with Kommerell’s diverticulum in 17 patients over an 18-year period. Even within a group with an interest in arch anomalies such interventions were performed about once a year. It is remarkable that only 6 of 17 patients were symptomatic. Dysphagia progresses so slowly that many affected individuals are not even aware of their abnormal swallowing and are surprised by the strikingly different swallowing experience after the aberrant subclavian artery and diverticulum have been removed. However, in light of how well most patients are able to compensate for swallowing difficulties, it is imperative that our surgical treatment carry minimal mortality and morbidity. These authors have demonstrated outstanding results in the elective setting. Given the relatively focal aortic disease the option of endovascular treatment has been favorably considered by an increasing number of cardiovascular surgeons. In most instances the distance between the two subclavian arteries, which are typically 90 degrees off axis of each other, remains exceedingly short such that to achieve a seal at the proximal landing zone requires bilateral carotid-subclavian bypass/transposition. Even after adequate seal is achieved, the aberrant subclavian artery remains in situ and can continue to provide ongoing swallowing difficulty. Because most patients present early in their adult life an open intervention remains a low risk endeavor with predictably good long-term results. We have historically undertreated aberrant subclavian artery with Kommerell’s diverticulum for fear of causing more harm than good: Clearly only a high volume aortic center should tackle these rare anomalies to ensure negligible risk. The surgical treatment of aberrant subclavian artery should include removal of the aberrant vessel with suitable revascularization plus excision of Kommerell’s diverticulum with appropriate aortic reconstruction. Endovascular treatment should be considered in high-risk patients primarily to treat impending rupture. Graft Replacement of Kommerell Diverticulum and In Situ Aberrant Subclavian Artery ReconstructionThe Annals of Thoracic SurgeryVol. 107Issue 3PreviewThis study aimed to evaluate the early and long-term outcomes of graft replacement of Kommerell diverticulum and in situ reconstruction of aberrant subclavian arteries in adults. Full-Text PDF